Clinical Trial

Treatment with Antiviral Therapies for Chronic Hepatitis C

Study Description

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network - A Longitudinal, Observational Study.

Clinical Trial ID

NCT01474811

ParticipAid ID

QeZY6d